Screener
Castle Biosciences CSTL Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
| ASSETS | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Commitments and Contingencies (Note 12) | ||
| Stockholders’ Equity | ||
| Preferred stock, $0.001 par value per share; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value per share; 200,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 30,295,965 and 29,686,314 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 30 | 30 |
| Additional paid-in capital | 700,255 | 694,860 |
| Accumulated deficit | (238,806) | (224,284) |
| Accumulated other comprehensive (loss) income | (63) | 267 |
| Total stockholders’ equity | 461,416 | 470,873 |
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's common stock, par value (in dollars per share)?
- Castle Biosciences (CSTL) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Castle Biosciences's common stock, par value (in dollars per share) changed year-over-year?
- Castle Biosciences's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Castle Biosciences's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Castle Biosciences's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Castle Biosciences's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude